| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |